JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2006, 55(5):203-209

New Systems for Colonic Drug Targeting

L. Janovská, D. Vetchý, M. Rabišková
Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav technologie léků

Colonic drug delivery systems are useful for the treatment of inflammatory bowel diseases (ulcerative colitis, Crohn's disease), some carcinomas, gastrointestinal infections and diseases that are sensitive to circadian rhythms, such as asthma, angina pectoris and arthritis, where an intention time delay in the absorption of the drug is required. The colon region is a site for the entry of peptides, proteins, nucleotides and vaccines into the systemic circulation due to local absence of digestive enzymes. Colonic drug targeting ensures direct treatment at the disease site and a possible reduction in the administered dose. A drug is not absorbed into the systemic circulation, so the associated systemic adverse effects are reduced. Colonic drug delivery systems are based on exploitation of characteristics that are unique to the gastrointestinal tract (GIT), such as pH gradient along the GIT, long transit time through the GIT, increased intraluminal pressure and a presence of bacterial microflora in these regions.

Keywords: drug targeting; colon; oral administration; new systems

Received: April 7, 2006; Accepted: May 30, 2006; Published: May 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janovská L, Vetchý D, Rabišková M. New Systems for Colonic Drug Targeting. Čes. slov. farm. 2006;55(5):203-209.
Download citation

References

  1. Basit, A. W.: Drugs, 2005; 65, 1991-2007. Go to original source... Go to PubMed...
  2. Chourasia, M. K., Jain, S. K.: J. Pharm. Pharmaceut. Sci., 2003; 6, 33-66.
  3. Evans, D. F., Pye, G. Bramley, R. et al.: Gut, 1988; 29, 1035-1041. Go to original source... Go to PubMed...
  4. Friend, D. R.: Adv. Drug. Deliv. Rev., 2005; 57, 247-265. Go to original source... Go to PubMed...
  5. http://www.aislp.cz 12.11. 2005.
  6. Wilding, I. R.: Drug Deliv. Tech., 2001; 1, 8-11.
  7. Knuth, K., Amiji, M., Robinson, J. R.: Adv. Drug Deliv. Rev., 1993; 11, 137-167. Go to original source...
  8. Stevens, H. N. E., Wilson, C. G., Welling, P. G. et al.: Int. J. Pharm., 2002; 236, 27-34. Go to original source... Go to PubMed...
  9. Binns, J. S., Stevens, H. N. E., McEwen, J. et al.: J. Control. Rel., 1996; 38, 151-158. Go to original source...
  10. Sangalli, M. E., Maroni, A., Zema, L. et al.: J. Control. Rel., 2001; 73, 103-110. Go to original source... Go to PubMed...
  11. Skalsky, B., Rudolph, M., Renner, G., http://www.roehm.de/en/pharmapolymers/drug_delivery/eudracole.Par.0002.TRow.0002.TCell.0002.File.tmp/EUDRACOL%20Abstract%20CRS%202004.pdf 15. 10. 2005.
  12. Bott, C., Rudolph, M. W., Schneider, A. R. J. et al.: Aliment. Pharmacol. Ther., 2004; 20, 347-353. Go to original source... Go to PubMed...
  13. Takaya, T., Ikeda, C., Imagawa, N. et al.: J. Pharm. Pharmacol., 1995; 47, 474-478. Go to original source... Go to PubMed...
  14. Yang, L., Chu, J. S., Fix, J. A.: Int. J. Pharm., 2002; 235, 1-15. Go to original source... Go to PubMed...
  15. Abu Shamat, M.: Int. J. Pharm., 1993; 97, 1-13. Go to original source...
  16. Sinha, V. R., Kumria, R.: Eur. J. Pharm. Sci., 2003; 18, 3-18. Go to original source... Go to PubMed...
  17. Sinha, V. R., Kumria, R.: Pharm. Res., 2001; 18, 557-564. Go to original source... Go to PubMed...
  18. Masteiková, R., Chalupová, Z., Šklubalová, Z.: Medicina, 2003; 39, 19-24.
  19. Chalupová, Z., Masteiková, R., Savickas, A.: Čes. slov. Farm., 2005; 54, 55-59.
  20. Sedláková, M., Rabišková,M., Spilková, J.: Čes. slov. Farm., 2006; 55, 4-11.
  21. Yang, L., Watanabe, S., Li, J. et al.: Pharm. Res., 2003; 20, 429-434. Go to original source... Go to PubMed...
  22. De Boever, P., Deplancke, B., Verstraete, W.: J. Nutr., 2000; 130, 2599-2606. Go to original source... Go to PubMed...
  23. Ullmann, V., http://astronuklfyzika.cz/Scintigrafie.htm 12.12. 2005.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.